首页> 外文期刊>Molecular medicine reports >Effects of focal mild hypothermia on thrombin-induced brain edema formation and the expression of protease activated receptor-1, matrix metalloproteinase-9 and aquaporin 4 in rats
【24h】

Effects of focal mild hypothermia on thrombin-induced brain edema formation and the expression of protease activated receptor-1, matrix metalloproteinase-9 and aquaporin 4 in rats

机译:亚低温对凝血酶诱导的脑水肿形成及蛋白酶激活受体1,基质金属蛋白酶9和水通道蛋白4表达的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypothermia is an effective neuroprotective treatment for brain injury caused by intracerebral hemorrhage (ICH). It is reported to reduce brain edema and neuronal cell death. Thrombin, a coagulation protease released from blood clots, is critical in brain edema formation following ICH. Protease activated receptor-1 (PAR-1), matrix metalloproteinase-9 (MMP-9) and aquaporin 4 (AQP4) are edema-associated mediators that have been implicated in ICH pathology. In the present study, thrombin was used to induce brain edema in adult male Sprague-Dawley rats. Differences between a focal mild hypothermic group (33 +/- 0.5 degrees C) and a normothermic group (37 degrees C) were investigated. Following hypothermia, brain water content and blood-brain barrier (BBB) disruption was assessed at 6, 24 and 48 h and subsequently at 3, 5 and 7 days. At the same time, the mRNA and protein expression of PAR-1, MMP-9 and AQP4 were also determined. It was identified that brain water content and BBB disruption increased at 6 h and reached a maximal level at 24 h in the normothermic group. The mRNA and protein expression levels of PAR-1, MMP-9 and AQP4 started to increase at 24 h and reached a maximal level at 48 h. Focal mild hypothermia tended to significantly reduce brain water content, BBB disruption and PAR-1, MMP-9 and AQP expression at 24 and 48 h. The present data suggest that focal mild hypothermia is an effective treatment for edema formation through moderation of the mRNA and protein expression of PAR-1, MMP-9 and AQP4.
机译:体温过低是对因脑出血(ICH)引起的脑损伤的有效神经保护疗法。据报道可减少脑水肿和神经元细胞死亡。凝血酶是一种从血块中释放出来的凝血蛋白酶,对脑出血后脑水肿的形成至关重要。蛋白酶激活受体1(PAR-1),基质金属蛋白酶9(MMP-9)和水通道蛋白4(AQP4)是与水肿相关的介质,已与ICH病理学有关。在本研究中,凝血酶被用于诱发成年雄性Sprague-Dawley大鼠的脑水肿。研究了局部轻度低温组(33 +/- 0.5摄氏度)和常温组(37摄氏度)之间的差异。体温过低后,分别在第6、24和48小时以及随后的3、5和7天评估脑水含量和血脑屏障(BBB)破坏。同时,还测定了PAR-1,MMP-9和AQP4的mRNA和蛋白表达。可以确定,常温组的脑水含量和BBB破坏在6 h时增加,并在24 h达到最高水平。 PAR-1,MMP-9和AQP4的mRNA和蛋白质表达水平在24小时开始增加,并在48小时达到最高水平。局部轻度体温过低往往会在24和48 h时显着降低脑含水量,BBB破坏以及PAR-1,MMP-9和AQP表达。本数据表明局灶性亚低温是通过调节PAR-1,MMP-9和AQP4的mRNA和蛋白表达来有效治疗水肿的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号